The meeting announced below concerns Human Immunodeficiency Virus (HIV) Prevention Projects for Young Men of Color Who Have Sex with Men and Young Transgender Persons of Color, Funding Opportunity Announcement (FOA) PS11-1113, initial review.
In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting:
Times and Dates: 8 a.m.-7 p.m., July 22, 2011 (Closed).
Place: Corporate Square, Building 8, Atlanta, Georgia 30333.
Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.
Matters to be Discussed: The meeting will include the initial review, discussion, and evaluation of applications received in response to “HIV Prevention Projects for Young Men of Color Who Have Sex with Men and Young Transgender Persons of Color, FOA PS11-1113.” This subsequent meeting to the July 10-13, 2011 meeting published in the Federal Register on February 22, 2011, Volume 76, Number 35, Pages 9785-9786 has been scheduled due to the high volume of applications received and unanticipated scheduling conflicts for a significant number of the appointed reviewers.
Contact Person for More Information: Harriette Lynch, Public Health Analyst, Extramural Programs, National Center for HIV, Hepatitis and Sexually Transmitted Diseases Prevention, CDC, 1600 Clifton Road, NE., Mailstop E-60, Atlanta, Georgia 30333, Telephone (404) 498-2726, E-mail HLynch@cdc.gov.
The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention, and the Agency for Toxic Substances and Disease Registry.Start Signature
Dated: June 30, 2011.
Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. 2011-17008 Filed 7-6-11; 8:45 am]
BILLING CODE 4163-18-P